Stay updated with breaking news from Zai Lab Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cullinan Therapeutics, Inc. announced positive initial data in patients receiving zipalertinib after prior treatment with amivantamab enrolled in its pivotal Phase 2b REZILIENT1 clinical trial. As of...
Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $18.46, but opened at $17.73. Zai Lab shares last traded at $17.83, with a volume of 35,690 shares. Analyst Upgrades and Downgrades Separately, Citigroup reduced their target price on Zai Lab from […]
Baron Funds, an investment management company, released its “Baron Emerging Markets Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on...
Baader Bank Aktiengesellschaft acquired a new stake in Zai Lab Limited (NASDAQ:ZLAB – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 9,284 shares of the company’s stock, valued at approximately $253,000. A number of other large investors have also added […]